PRESENTATION TITLES:
1. Endocrine Sensitivity of ER+/HER2- Breast Cancer Associated with Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
2. Postpartum Breast Cancer

PRESENTERS:
Siddhartha Yadav, MBBS, MD, and Dame Idossa, MD

VIEWING LOCATION:
In-Person: Gonda 2-101 Mathy Hall and Virtually on Teams
Light Breakfast refreshments provided.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

• Assess the utility of biomarkers associated with endocrine sensitivity in germline pathogenic variant carriers.
• Evaluate clinical outcomes of ER+/HER2- breast cancer in carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
• Define pregnancy related breast cancer (PrBC) and postpartum breast cancer (PPBC)
• Evaluate clinical outcomes of women with postpartum breast cancer
• Evaluate the impact of involution on breast cancer outcomes

ATTENDANCE / CREDIT:
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT:
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Sheila Terrill, Education Specialist - GIM CME